TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Genscript Biotech ( (HK:1548) ) has provided an announcement.
Genscript Biotech Corporation has announced the redesignation of Dr. Ross Allen Grossman from a non-executive Director to an independent non-executive Director, effective March 11, 2025. This change in the board’s composition reflects the company’s strategic focus on strengthening its governance structure, potentially enhancing its industry positioning and stakeholder confidence.
More about Genscript Biotech
Genscript Biotech Corporation is a company incorporated in the Cayman Islands, operating in the biotechnology sector. The company, along with its subsidiaries, focuses on providing innovative solutions in the biotech industry.
YTD Price Performance: 13.39%
Average Trading Volume: 3,834
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $3.72B
For detailed information about 1548 stock, go to TipRanks’ Stock Analysis page.